SERPINA1 and alpha 1-antitrypsin deficiency: A recent prospective study revealed that double-dose augmentation therapy of 120 mg AAT/kg b.w. per week increased AAT levels to normal and reduced serine protease activities and hence markers of elastin degradation in bronchoalveolar lavage (BAL) fluids of patients with AATD (19).